These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8092756

  • 41. Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease.
    Milio G, Cospite V, Cospite M.
    Minerva Cardioangiol; 2003 Jun; 51(3):311-6. PubMed ID: 12867883
    [Abstract] [Full Text] [Related]

  • 42. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution].
    Visconti W, Grillo N.
    Minerva Med; 1985 May 12; 76(19-20):945-53. PubMed ID: 3158842
    [Abstract] [Full Text] [Related]

  • 43. Effect of percutaneous transluminal angioplasty on tissue oxygenation in ischemic diabetic feet.
    Kim HR, Han SK, Rha SW, Kim HS, Kim WK.
    Wound Repair Regen; 2011 May 12; 19(1):19-24. PubMed ID: 21134031
    [Abstract] [Full Text] [Related]

  • 44. Dialysis clearance of buflomedil in hemodialysed patients.
    Rey E, Moynot A, d'Athis P, Pello JY, Maurel A, Frydman MO, Buisson C, Olive G.
    Arzneimittelforschung; 1996 May 12; 46(5):492-5. PubMed ID: 8737633
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V, Margheriti R, Matone P, Morrieri C, Rugolo A, Corsi V.
    Clin Ter; 1986 Jun 30; 117(6):499-509. PubMed ID: 3527536
    [No Abstract] [Full Text] [Related]

  • 47. [Acute severe coronary insufficiency during intravenous therapy with buflomedil hydrochloride. Description of 4 cases].
    Romanò M, Spinelli A, Muzio L, Cazzani E, Baldini MR.
    Minerva Cardioangiol; 1988 Sep 30; 36(9):451-5. PubMed ID: 3226575
    [No Abstract] [Full Text] [Related]

  • 48. Letter by De Backer et al regarding article, "Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study".
    De Backer TL, Vander Stichele RH, Van Bortel LM.
    Circulation; 2008 Sep 02; 118(10):e151. PubMed ID: 18765384
    [No Abstract] [Full Text] [Related]

  • 49. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
    Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T.
    J Int Med Res; 1984 Sep 02; 12(3):188-92. PubMed ID: 6734922
    [No Abstract] [Full Text] [Related]

  • 50. [Percutaneous transluminal angioplasty. An efficient alternative in the treatment of peripheral obstructive arteriopathy].
    Kisileczky N, Carvalho A, Leão PP, Magalhães AC.
    Rev Hosp Clin Fac Med Sao Paulo; 1995 Sep 02; 50(4):185-8. PubMed ID: 8560146
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Multicentre clinical placebo-controlled study with buflomedil in the treatment of mild dementia of vascular origin.
    Cucinotta D, Aveni Casucci MA, Pedrazzi F, Ponari O, Capodaglio M, Valdina P, Toxiri I, Bartorelli L, Granata Q, Franzini C.
    J Int Med Res; 1992 Apr 02; 20(2):136-49. PubMed ID: 1521670
    [Abstract] [Full Text] [Related]

  • 54. Double-blind placebo-controlled trial of buflomedil in the treatment of Raynaud's phenomenon: six-month follow-up.
    Le Quentrec P, Lefebvre ML.
    Angiology; 1991 Apr 02; 42(4):289-95. PubMed ID: 1673051
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec 02; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication].
    Meilhac B, Montestruc F, Aubin F, Djian F, Rouffy J.
    Therapie; 1997 Dec 02; 52(3):179-86. PubMed ID: 9366101
    [Abstract] [Full Text] [Related]

  • 59. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P, Pagratis N.
    Angiology; 1981 Oct 02; 32(10):679-85. PubMed ID: 7325404
    [No Abstract] [Full Text] [Related]

  • 60. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S, Manganaro A, Barbera MC, Cento D, Buda D, Arrigo F, Consolo F.
    Minerva Cardioangiol; 1986 Nov 02; 34(11):745-9. PubMed ID: 2949163
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.